Milestone scientific achieves revenue of $2.7 million and provides business update for the first quarter of 2022

Roseland, n.j., may 17, 2022 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended march 31, 2022.
MLSS Ratings Summary
MLSS Quant Ranking